| After pharmacy deals, new opioid sellers in legal ‘bull’s-eye’ Law360: Andrew Pollis, professor of law, noted that multibillion-dollar settlements with top pharmacy retailers will shift a historic barrage of opioid litigation away from the last of its early targets and toward groups of pharmaceutical sellers and advisers. |
